| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Endocrine Business Unit | Chief Commercial Officer
1 company
Galindo Alejandro is an EVP Endocrine Business Unit at MANNKIND CORP. Recent SEC Form 4 filings include 5 buys and 2 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 | MNKD Mannkind Corp | EVP Endocrine Business Unit | Sell | 4,615 | $3.85 | $17,770.82 | -0.3% | +11.4% | +17.6% | |
| Jul 31, 2022 | MNKD Mannkind Corp | EVP Endocrine Business Unit | Buy | 5,000 | $2.93 | $14,650.00 | +0.6% | -2.5% | +27.7% | |
| Feb 28, 2022 | MNKD Mannkind Corp | Chief Commercial Officer | Buy | 36,900 | $2.71 | $99,999.00 | +6.8% | +59.5% | +101.5% | |
| Jan 31, 2022 | MNKD Mannkind Corp | Chief Commercial Officer | Buy | 2,334 | $3.17 | $7,398.78 | +0.4% | -12.1% | +46.6% | |
| Jul 30, 2021 | MNKD Mannkind Corp | Chief Commercial Officer | Buy | 5,000 | $2.99 | $14,950.00 | +0.9% | +17.1% | -15.9% | |
| Nov 14, 2018 | MNKD Mannkind Corp | Chief Commercial Officer | Buy | 34,602 | $2.89 | $99,999.78 | +9.5% | - | - |